Skip to main content
FOI release

FOI – 000271 Volume of Coagulation Factor Distributed to NHS Hospitals (HTML)

Published on 08 October 2022

Date received - 29 October 2022 | Date responded - 08 November 2022


I would like to submit an FOI request for the volume of coagulation factor (in IU or mg) distributed to NHS Scotland Hospitals in each month from July 2022 through September 2022 (July 1st to September 30th), broken down by product (see below). If the volume by brand is not available, I would like to request the number of vials distributed by brand. If possible, I would also like the number of patients by brand. Thank you very much for your time and assistance:

  • Hemlibra
  • Obizur
  • Esperoct
  • Idelvion
  • Adynovi
  • Refixia
  • Elocta
  • Alprolix
  • NovoEight
  • BeneFIX
  • Advate
  • Replenine
  • ReFacto AF
  • Rixubis
  • Nuwiq
  • Obizur
  • NovoSeven
  • Idelvion


I refer to your freedom of information request that we received on 29 October 2022. I can advise you that we have now completed the search of our records and can provide you with the following information:

Please find attached, Appendix 1 - Coagulation Factor Extract Secondary-Homecare data.

Under Section 17 of the Freedom of Information Scotland Act an organisation does not require to provide information if it does not hold that information. NHS National Services Scotland (NSS) does not hold some of this information as detailed below:

  • Supply data on appendix 1 shows the volume of product supplied to patients via homecare only, as hospital supply data is unavailable for the period requested. This is due to NSS Procurement, Commissioning and Facilities (PCF) only receiving this data on an ad-hoc basis from an external body, the Commercial Medicines Unit (CMU). We recommend contacting CMU at or who may be able to provide these figures.

  • The most recent hospital supply data available is included in a previous FOI response that is published on the NSS website. Please see the following link FOI 000098: Volume of coagulation factor distributed to NHS Scotland Hospitals from Jan '22 to Mar '22 | National Services Scotland.

  • NSS PCF has been unable to retrieve supply data for several of the requested brands detailed within the top line on Appendix 1. This could be due to there being no usage of these brands.

  • The number of patients by brand has been provided for homecare supply but please note, where the number of patients are fewer than 5, the detail has been redacted under Section 38 (1) (b) of FOISA to ensure no patient identifiable information is released in line with Caldicott Principles.

I trust you will find the information of assistance and if you require any further information please do not hesitate to contact us.

If you are unhappy with any aspect of how we have dealt with your request you can make representations to us asking us to review the handling of your request.

If you require any further information please contact Associate Director Information Security & Governance, within 40 working days of the date of this correspondence.




NHS National Services Scotland Headquarters Gyle Square 1 South Gyle Crescent Edinburgh EH12 9EB

If after a review you are still unhappy, you also have the right to apply to the Scottish Information Commissioner, who can be contacted at Kinburn Castle, St Andrews, Fife, KY16 9DS, or via their application form.

National Services Scotland (NSS) is committed to publishing all information released in response to Freedom of Information requests. You can view all FOI responses within our FOI Publications repository.